Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect
Zhiyi Xia, Xue Li, Adong Shen, Igor Mokrousov, Pengbo Guo, Yaodong Zhang

TL;DR
This study tracks how HRSV infections in children in central China changed over six years, showing a big increase after pandemic restrictions were lifted due to immune debt.
Contribution
The study provides empirical evidence supporting the 'immune debt' theory through detailed HRSV epidemiological data in post-pandemic China.
Findings
HRSV positivity surged to 21.47% in 2023 after NPIs were lifted, with a strong odds ratio of 668.77.
Infants under one year had a 9.02-fold higher risk of HRSV infection compared to older children.
The 2023 outbreak occurred in spring, breaking the typical winter season pattern.
Abstract
Human respiratory syncytial virus (HRSV) is a leading cause of acute respiratory infections in children. COVID-19 NPIs significantly suppressed HRSV transmission. This study analyzed six-year epidemiological dynamics of pediatric HRSV infections in Henan Province, China, focusing on NPI suppression effects, the 2023 resurgence, and “Immune debt” impact. We retrospectively collected respiratory specimens from 80,920 children with acute respiratory diseases at Henan Children’s Hospital (2019-2024). HRSV was detected using RT-qPCR. Positivity rates were analyzed by year, season, and age group. During 2019–2024, HRSV positivity fluctuated markedly: 14.65% (2019), 16.34% (2021), 3.27% (2022 under strict NPIs), 21.47% (2023 post-NPIs), and 6.80% (2024). Interrupted time-series analysis indicated that NPI lifting in 2023 was associated with a significant surge in infection risk (OR = 668.77,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRespiratory viral infections research · COVID-19 Clinical Research Studies · Cystic Fibrosis Research Advances
